Literature DB >> 32402299

Primary Liver Cancers: Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma.

Juan C Mejia1, Jennifer Pasko2.   

Abstract

The incidence of liver cancers has continued to increase over the past few decades and mortality related to liver cancer has increased by more than 2% annually since 2007. This article reviews the essential workup and treatment options necessary for general surgeons as they treat patients with primary liver cancers.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cholangiocarcinoma; Cirrhosis; Hepatocellular carcinoma; Intrahepatic cholangiocarcinoma; Liver resection; Primary liver cancers

Mesh：

Year:  2020        PMID： 32402299     DOI： 10.1016/j.suc.2020.02.013

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN： 0039-6109            Impact factor:   2.741


  14 in total

1.  Use of X-Ray Fluorescence Microscopy for Studies on Research Models of Hepatocellular Carcinoma.

Authors:  Tatjana Paunesku; Andrew C Gordon; Sarah White; Kathleen Harris; Olga Antipova; Evan Maxey; Stefan Vogt; Anthony Smith; Luiza Daddario; Daniele Procissi; Andrew Larson; Gayle E Woloschak
Journal:  Front Public Health       Date:  2021-08-20

2.  Primary tumor resection improves survival in patients with multifocal intrahepatic cholangiocarcinoma based on a population study.

Authors:  Linlin Yin; Si Zhao; Hanlong Zhu; Guozhong Ji; Xiuhua Zhang
Journal:  Sci Rep       Date:  2021-06-09       Impact factor: 4.379

3.  C8B in Complement and Coagulation Cascades Signaling Pathway is a predictor for Survival in HBV-Related Hepatocellular Carcinoma Patients.

Authors:  Yuan Zhang; Xiaorong Chen; Yajuan Cao; Zongguo Yang
Journal:  Cancer Manag Res       Date:  2021-04-22       Impact factor: 3.989

4.  The Prognostic Value of the Albumin to Gamma-Glutamyltransferase Ratio in Patients with Hepatocellular Carcinoma Undergoing Radiofrequency Ablation.

Authors:  Wenfeng Liu; Feng Zhang; Bing Quan; Miao Li; Shenxin Lu; Jinghuan Li; Rongxin Chen; Xin Yin
Journal:  Dis Markers       Date:  2021-11-19       Impact factor: 3.434

5.  Study on the Application of Doxorubicin-Loaded Magnetic Nanodrugs in Targeted Therapy of Liver Cancer.

Authors:  Lei Wang; Liping Liang; Shuzhen Shi; Chao Wang
Journal:  Appl Bionics Biomech       Date:  2022-02-22       Impact factor: 1.781

Review 6.  The Bright and the Dark Side of TGF-β Signaling in Hepatocellular Carcinoma: Mechanisms, Dysregulation, and Therapeutic Implications.

Authors:  Medine Zeynep Gungor; Merve Uysal; Serif Senturk
Journal:  Cancers (Basel)       Date:  2022-02-14       Impact factor: 6.639

7.  Lactate promotes the growth of patient-derived organoids from hepatopancreatobiliary cancers via ENO1/HIF1α pathway and does not affect their drug sensitivities.

Authors:  Zhiwei Wang; Yuanquan Yu; Peiyao Wu; Qinghuang Ye; Yinghao Guo; Xiaoxiao Zhang; Longfu Xi; Qi Li; Yun Jin; Donger Zhou; Yan Luo; Shuyou Peng; Jiangtao Li
Journal:  Cell Death Discov       Date:  2022-04-20

8.  Ferroptosis in Intrahepatic Cholangiocarcinoma: IDH1105GGT Single Nucleotide Polymorphism Is Associated With Its Activation and Better Prognosis.

Authors:  Samantha Sarcognato; Diana Sacchi; Luca Fabris; Giacomo Zanus; Enrico Gringeri; Monia Niero; Giovanna Gallina; Maria Guido
Journal:  Front Med (Lausanne)       Date:  2022-07-08

9.  Clinical Effect of Iodine-125 Seed Implantation in Patients with Primary Liver Cancer and Its Effect on Th1/Th2 Cells in Peripheral Blood.

Authors:  Xiaoyan Chen; Fan Zhu; Bin Wang; Yu Zhou; Hao Xiong; Tao Fan; Wenjie Ke
Journal:  J Oncol       Date:  2021-07-29       Impact factor: 4.375

10.  Absent in melanoma 1-like (AIM1L) serves as a novel candidate for overall survival in hepatocellular carcinoma.

Authors:  Wenliang Zhou; Yuan Zhang; Shixi Zhang; Zongguo Yang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.